Stock CLRB CELLECTAR BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cellectar Biosciences, Inc.

Equities

CLRB

US15117F8077

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
3.28 USD -1.50% Intraday chart for Cellectar Biosciences, Inc. +11.19% +18.41%
May. 29 Cellectar Biosciences, Inc. and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis fungoides CI
May. 14 Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CELLECTAR BIOSCIENCES, INC. Stock Cellectar Biosciences, Inc.
 119M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 765B
JOHNSON & JOHNSON Stock Johnson & Johnson
 354B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 331B
ABBVIE INC. Stock AbbVie Inc.
 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
 248B
  1. Stock Market
  2. Equities
  3. CLRB Stock
  4. Charts Cellectar Biosciences, Inc.
  5. Sector Chart